Hidradenitis Suppurativa Treatment Market Report 2025 (Global Edition)

Global Hidradenitis Suppurativa Treatment Market Report 2025 Market Size Split by Clinical Stages Outlook: (Hurley Stage 1- Low, Hurley Stage 2- Moderate, Hurley Stage 3- High), by Treatment Type Outl...

Hidradenitis Suppurativa Treatment Market Report Description

We have various report editions of Hidradenitis Suppurativa Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Hidradenitis Suppurativa Treatment Market Insights Video

Competitive Landscape of the Hidradenitis Suppurativa Treatment Market

Leading market participants are making substantial investments in research and development to broaden their product offerings, which will contribute to the continued expansion of the Hidradenitis Suppurativa market. Additionally, market participants are engaging in a diverse array of strategic initiatives to broaden their market presence. These initiatives include the introduction of new products, contractual agreements, mergers and acquisitions, increased investments, and partnerships with other organizations. The Hidradenitis Suppurativa industry must provide cost-effective products in order to expand and endure in a more competitive and evolving market.

In June 2022, Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus were released by Riovant and Pfizer. (Source: https://www.pfizer.com/news/press-release/press-release-detail/roivant-and-pfizer-unveil-priovant-therapeutics-and-ongoing) In March 2022, MoonLake Immunotherapeutics has initiated an international Phase II clinical trial of the experimental nanobody sonelokimab to treat moderate-to-severe hidradenitis suppurativa (HS). (Source: https://ir.moonlaketx.com/news-releases/news-release-details/moonlake-immunotherapeutics-starts-phase-2-trial-nanobodyr) In February 2021, AbbVie Inc. granted FDA approval to HUMIRA (adalimumab), a medication for the treatment of moderate to severe hidradenitis suppurativa. (Source: https://news.abbvie.com/2016-06-30-AbbVies-HUMIRA-adalimumab-Receives-U-S-Food-and-Drug-Administration-Approval-to-Treat-Adults-with-Non-Infectious-Intermediate-Posterior-and-Panuveitis#:~:text=HUMIRA%20is%20approved%20for%20use,arthritis%2C%20moderately%20to%20severely%20active)

Top Companies Market Share in Hidradenitis Suppurativa Treatment Industry: (In no particular order of Rank)

• InflaRx N.V
• Novartis A.G
• Incyte Corporation
• UCB Biopharma SPRL
• Janssen Pharmaceuticals
• Amgen Inc.
• ChemoCentryx
• Priovant Therapeutics
• AnaptysBio
• AbbVie Inc.
• ACELYRIN
• Aclaris Therapeutics Inc.
• Boehringer Ingelheim
• Eli Lilly and Company
• MoonLake Immunotherapeutics
• Aristea Therapeutics
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Hidradenitis Suppurativa Treatment Market

Which Region Dominates the Hidradenitis Suppurativa Treatment Market in 2024?

According to Cognitive Market Research, North America currently dominates the Hidradenitis Suppurativa Treatments market, and the region is expected to have significant growth during the projected period. This is a result of the increasing adoption of newer techniques in this region. Furthermore, the market's growth rate in this region will be further bolstered by the well-established healthcare infrastructure and the increasing presence of major key participants.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The reason for this is the increasing prevalence of inflammatory skin diseases, the growth of healthcare knowledge and government support, the proliferation of generic manufacturers, and the proliferation of government initiatives in this fieldx.

The current report Scope analyzes Hidradenitis Suppurativa Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Hidradenitis Suppurativa Treatment

According to Cognitive Market Research, the global Hidradenitis Suppurativa Treatment market size was estimated at USD 781.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 312.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Hidradenitis Suppurativa Treatment market with a market size of USD 246.64 million in 2024 and is anticipated to grow at a CAGR of 3.2% during the projected period. The U.S. market's growing incidence of chronic diseases and the development of new healthcare technologies.
• The Canada Hidradenitis Suppurativa Treatment market had a market share of USD 37.51 million in 2024 and is anticipated to grow at a CAGR of 4.2% during the projected period. Canada’s Increasing awareness and comprehension of HS among healthcare professionals and patients.
• The Mexico Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 3.9% during the projected period, with a market size of USD 28.45 million in 2024.

Europe Hidradenitis Suppurativa Treatment

According to Cognitive Market Research, the global Hidradenitis Suppurativa Treatment market size was estimated at USD 781.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 234.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• The United Kingdom Hidradenitis Suppurativa Treatment market had a market share of USD 39.39 million in 2024 and is anticipated to grow at a CAGR of 4.5% during the projected period. In the UK, Hidradenitis Suppurativa Treatment sales see an upswing due to Increased awareness and proactive treatment seeking.
• The France Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 2.9% during the projected period, with a market size of USD 21.57 million in 2024.
• According to Cognitive Market Research, the German Hidradenitis Suppurativa Treatment market size was valued at USD 46.42 million in 2024 and is anticipated to grow at a CAGR of 3.9% during the projected period. In Germany, Hidradenitis Suppurativa Treatment surged due to the Increasing investments in research and development initiatives.
• The Italy Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 3.1% during the projected period, with a market size of USD 20.16 million in 2024.
• The Russia Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 2.7% during the projected period, with a market size of USD 36.34 million in 2024.
• The Spain Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 2.8% during the projected period with a market size of USD 19.22 million in 2024
• The Luxembourg Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 3.8% during the projected period, with a market size of USD 7.27 million in 2024.
• The Portugal Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 3.5% during the projected period, with a market size of USD 4.92 million in 2024.
• The Greece Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 4.0% during the projected period, with a market size of USD 2.81 million in 2024.
• The Rest of Europe's Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 2.4% during the projected period, with a market size of USD 36.34 million in 2024.

Asia Pacific Hidradenitis Suppurativa Treatment

According to Cognitive Market Research, the global Hidradenitis Suppurativa Treatment market size was estimated at USD 781.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 179.75 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Hidradenitis Suppurativa Treatment market size was valued at USD 80.89 million in 2024 and is anticipated to grow at a CAGR of 6.7% during the projected period. Hidradenitis Suppurativa Treatment surged in China due to Increased funding from both public and private sectors and rapid advancements in the healthcare sector.
• The Japan Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 5.7% during the projected period, with a market size of USD 24.80 million in 2024.
• The India Hidradenitis Suppurativa Treatment market had a market share of USD 21.57 million in 2024 and is anticipated to grow at a CAGR of 9.0% during the projected period. India's Increased prevalence of HS and the advancement of novel therapies.
• The South Korean Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 6.3% during the projected period, with a market size of USD 17.97 million in 2024.
• The Australian Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 6.9% during the projected period, with a market size of USD 9.35 million in 2024.
• The South East Asia Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 8.2% during the projected period, with a market size of USD 12.40 million in 2024.
• The Rest of Asia Pacific Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 7.0% during the projected period, with a market size of USD 12.76 million in 2024.

South America Hidradenitis Suppurativa Treatment

According to Cognitive Market Research, the global Hidradenitis Suppurativa Treatment market size was estimated at USD 781.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 39.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Hidradenitis Suppurativa Treatment market size was valued at USD 16.72 million in 2024 and is anticipated to grow at a CAGR of 5.2% during the projected period. Hidradenitis Suppurativa Treatments flourished in Brazil due to Enhanced investment in research and development initiatives.
• Argentina's Hidradenitis Suppurativa Treatment market had a market share of USD 6.56 million in 2024 and is anticipated to grow at a CAGR of 5.5% during the projected period. Argentina's increasing incidence of dermatological conditions.
• Colombia Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 4.4% during the projected period, with a market size of USD 3.48 million in 2024.
• Peru Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 4.8% during the projected period, with a market size of USD 3.20 million in 2024.
• Chile Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 4.9% during the projected period, with a market size of USD 2.81 million in 2024.
• The Rest of Latin America's Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 3.7% during the projected period, with a market size of USD 6.29 million in 2024.

Middle East Hidradenitis Suppurativa Treatment

According to Cognitive Market Research, the global Hidradenitis Suppurativa Treatment market size was estimated at USD 781.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 15.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031..

• The GCC Countries Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 5.7% during the projected period, with a market size of USD 6.69 million in 2024. Hidradenitis Suppurativa Treatment sales flourish due to the Improvements in the technology and infrastructure of healthcare.
• The Egypt Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 5.2% during the projected period, with a market size of USD 1.64 million in 2024.
• The South Africa Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 5.9% during the projected period, with a market size of USD 2.47 million in 2024. Hidradenitis Suppurativa Treatment sales flourished in South Africa due to Increasing recognition and diagnosis of cutaneous conditions.
• The Turkey Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 4.4% during the projected period, with a market size of USD 1.34 million in 2024.
• The Nigeria Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 4.0% during the projected period, with a market size of USD 1.64 million in 2024.
• The Rest of the MEA Hidradenitis Suppurativa Treatment market is anticipated to see growth at a CAGR of 3.9% during the projected period, with a market size of USD 1.84 million in 2024.

Hidradenitis Suppurativa Treatment Market Analysis

How are Segments Performing in the Global Hidradenitis Suppurativa Treatment Market?

Hidradenitis Suppurativa Treatment Market Clinical Stages Segment Analysis

According to Cognitive Market Research, Hurley Stage 1 (Low) is likely to dominate the Hidradenitis Suppurativa Treatment Market over the forecast period. The most prevalent and pervasive stage is defined by benign symptoms, such as isolated abscesses or sores that do not result in significant fibrosis or sinus tract formation.

The Hurley Stage 3 (High) is the fastest-growing segment in the Hidradenitis Suppurativa Treatment Market. This stage is characterized by a significant amount of fibrosis and extensive, widespread involvement in multiple interconnected sinus tracts, which has resulted in a greater demand for advanced and aggressive treatment options.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Hidradenitis Suppurativa Treatment Industry. Request a Free Sample PDF!

Hidradenitis Suppurativa Treatment Market Treatment Type Segment Analysis

According to Cognitive Market Research, the Medications segment holds the largest share of the market because antibiotics, anti-inflammatory medicines, and other medications are administered to a large number of people in order to treat their symptoms.

In the Hidradenitis Suppurativa Treatment Market, the Biologics sector has been expanding at a rapid pace as a result of the development of targeted treatments that target the underlying immune response, patients now have access to therapy alternatives that are both more effective and more long-term.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Hidradenitis Suppurativa Treatment Route of Administration Outlook: Segment Analysis

Hidradenitis Suppurativa Treatment Market Route of Administration Segment Analysis

According to Cognitive Market Research, the Oral segment holds the largest market share because of the widespread use of oral antibiotics, anti-inflammatory medications, and other systemic therapies that are simple for patients to give and maintain on their own.

In the Hidradenitis Suppurativa Treatment market, the rapidly growing sector is the Topical category. Because of the development of more sophisticated topical formulations, which provide focused therapy with less systemic adverse effects, these formulations have become the preferred option for the initial and maintenance treatment of mild to moderate cases.

• Oral
• Tropical

Hidradenitis Suppurativa Treatment End Users Outlook: Segment Analysis

Hidradenitis Suppurativa Treatment Market End Users Segment Analysis

According to Cognitive Market Research, the Hospitals segment dominates the market owing to the fact that comprehensive treatment, cutting-edge medical technology, and highly trained medical experts are all readily available in a centralized establishment.

Homecare is projected to be the fastest-growing segment in the Hidradenitis Suppurativa Treatment market, driven by the growing preference for receiving treatment in the privacy of one's own home, the widespread adoption of telemedicine and remote monitoring technologies, and the advancements in-home healthcare services.

• Hospitals
• Homecare
• Specialty Clinics

Hidradenitis Suppurativa Treatment Distribution Channel Outlook: Segment Analysis

Hidradenitis Suppurativa Treatment Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the Hospital Pharmacy segment dominates the market due to the centralized availability of a diverse selection of medications and the presence of specialized healthcare specialists who can deliver immediate and comprehensive care.

Online Pharmacy is projected to be the fastest-growing segment in the Hidradenitis Suppurativa Treatment market driven by the growing accessibility and convenience of online purchasing, the increasing adoption of telemedicine, and the capacity to obtain medications without physically visiting a location.

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion